Chylomicrons in disease-future challenges. Invited keynote address

Atherosclerosis Supplements

Volumn 9, Issue 2, 2008, Pages 3-6

  Redgrave, Trevor G ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Atherosclerosis; Cardiovascular disease; Chylomicron remnants; Chylomicrons; Exercise; Nutrition; Postprandial dyslipidaemia

Indexed keywords

ADRENALIN; ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLESTEROL; CHYLOMICRON; FISH OIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROBUCOL; THYROMIMETIC AGENT; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; BAYES THEOREM; CAROTID ARTERY DISEASE; CHOLESTEROL INTAKE; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE COURSE; DRUG ABSORPTION; DYSLIPIDEMIA; EXERCISE; LIFESTYLE MODIFICATION; LIPOPROTEIN METABOLISM; LOW FAT DIET; MEDITERRANEAN DIET; METABOLIC CLEARANCE RATE; NONHUMAN; NUTRITION; PATHOPHYSIOLOGY; POSTPRANDIAL DYSLIPIDEMIA; POSTPRANDIAL STATE; PRIORITY JOURNAL; REMISSION; RISK FACTOR; RISK REDUCTION; TREATMENT PLANNING; WEIGHT REDUCTION;

ANTILIPEMIC AGENTS; ATHEROSCLEROSIS; CHYLOMICRONS; DYSLIPIDEMIAS; EXERCISE; HUMANS; LIFE STYLE; POSTPRANDIAL PERIOD; RISK FACTORS;

EID: 50449091322     PISSN: 15675688     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosissup.2008.05.002     Document Type: Article

References (36)

1. Jeffery F., and Redgrave T.G. Chylomicron catabolism differs between Hooded and albino laboratory rats. J Lipid Res 23 (1982) 154-160
2. Redgrave T.G., and Small D.M. Quantitation of the transfer of surface phospholipid of chylomicrons to the high density lipoprotein fraction during the catabolism of chylomicrons in the rat. J Clin Invest 64 (1979) 162-171
3. Martins I.J., Vilcheze C., Mortimer B.C., Bittman R., and Redgrave T.G. Sterol side chain length and structure affect the clearance of chylomicron-like lipid emulsions in rats and mice. J Lipid Res 39 (1998) 302-312
4. Watts G.F., Mamo J.C., and Redgrave T.G. Postprandial dyslipidaemia in a nutshell: food for thought. Aust N Z J Med 28 (1998) 816-823
5. Lopez-Miranda J., Williams C., and Lairon D. Dietary, physiological, genetic and pathological influences in postprandial lipid metabolism. Brit J Nutr 98 (2007) 458-473
6. Groot P.H., van Stiphout W.A., Krauss X.H., et al. Postprandial lipoprotein metabolism in normolipidemic men with and without coronary artery disease. Arterioscler Thromb 11 (1991) 653-662
7. Karpe F., Steiner G., Uffelman K., Olivecrona T., and Hamsten A. Postprandial lipoproteins and progression of coronary atherosclerosis. Atherosclerosis 106 (1994) 83-97
8. Weintraub M.S., Grosskopf I., Rassin T., et al. Clearance of chylomicron remnants in normolipidemic patients with coronary artery disease: case control study over three years. Brit Med J 312 (1996) 936-939
9. Kugiyama K., Doi H., Takazoe K., et al. Remnant lipoprotein levels in fasting serum predict coronary events in patients with coronary artery disease. Circulation 99 (1999) 2858-2860
10. Ryu J.E., Howard G., Craven T.E., et al. Postprandial triglyceridemia and carotid atherosclerosis in middle-aged subjects. Stroke 23 (1992) 823-828
11. Sharrett A.R., Chambless L.E., Heiss G., Paton C.C., and Patsch W. Association of postprandial triglyceride and retinyl palmitate responses with asymptomatic carotid artery atherosclerosis in middle-aged men and women-the atherosclerosis risk in communities (ARIC) study. Arterioscler Thromb Vasc Biol 15 (1995) 2122-2129
12. Karpe F., de Faire U., Mercuri M., et al. Magnitude of alimentary lipemia is related to intima-media thickness of the common carotid artery in middle-aged men. Atherosclerosis 141 (1998) 307-314
13. Boquist S., Ruotolo G., Tang R., et al. Alimentary lipemia, postprandial triglyceride-rich lipoproteins, and common carotid intima-media thickness in healthy, middle-aged men. Circulation 100 (1999) 723-728
14. Proctor S.D., and Mamo J.C. Arterial fatty lesions have increased uptake of chylomicron remnants but not low-density lipoproteins. Coron Artery Dis 7 (1996) 239-245
15. Mamo J.C.L., Proctor S.D., and Smith D. Retention of chylomicron remnants by arterial tissue; importance of an efficient clearance mechanism from plasma. Atherosclerosis 141 (1998) S63-S69
16. Batt K.V., Avella M., Moore E.H., et al. Differential effects of low-density lipoprotein and chylomicron remnants on lipid accumulation in human macrophages. Exp Biol Med 229 (2004) 528-537
17. Bejta F., Moore E., Avella M.P.J.G., Suckling K., and Botham K. Oxidation of chylomicron remnant-like particles inhibits their uptake by THP-1 macrophages by apolipoprotein E-dependent processes. Biochim Biophys Acta 1771 (2007) 901-910
18. Martins I.J., Mortimer B.C., Miller J., and Redgrave T.G. Effects of particle size and number on the plasma clearance of chylomicrons and remnants. J. Lipid Res 37 (1996) 2696-2705
19. Mortimer B.C., Kenrick M.A., Holthouse D.J., Stick R.V., and Redgrave T.G. Plasma clearance of model lipoproteins containing saturated and polyunsaturated monoacylglycerols injected intravenously in the rat. Biochim Biophys Acta 1127 (1992) 67-73
20. Mortimer B.C., Holthouse D.J., Martins I.J., Stick R.V., and Redgrave T.G. Effects of triacylglycerol-saturated acyl chains on the clearance of chylomicron-like emulsions from the plasma of the rat. Biochim Biophys Acta 1211 (1994) 171-180
21. Redgrave T.G., Kodali D.R., and Small D.M. The effect of triacyl-sn-glycerol structure on the metabolism of chylomicrons and triacylglycerol-rich emulsions in the rat. J Biol Chem 263 (1988) 5118-5123
22. Cesar T., Oliveira M., Mesquita C., and Maranhao R. High cholesterol intake modifies chylomicron metabolism in normolipidemic young men. J Nutr 136 (2006) 971-976
23. Karpe F., Bickerton A., Hodson L., et al. Removal of triacylglycerols from chylomicrons and VLDL by capillary beds: the basis of lipoprotein remnant formation. Biochem Soc Trans 35 (2007) 472-476
24. Redgrave T.G. Formation and metabolism of chylomicrons. Int Rev Physiol 28 (1983) 103-130
25. Martins I.J., Tran J.M.L., and Redgrave T.G. Food restriction normalizes chylomicron remnant metabolism in murine models of obesity as assessed by a novel stable isotope breath test. J Nutr 132 (2002) 176-181
26. Mackintosh V., and Redgrave T.G. Effects of adrenaline and noradrenaline on clearance of triacylglycerol-rich lipoprotein from plasma. Studies with lipid emulsions in rats. Clin Exp Pharmacol Physiol 18 (1991) 137-143
27. Mackintosh V.S., Phan C.T., Mortimer B.C., and Redgrave T.G. Vasoactive mediators affect the clearance of lipids from emulsion models of plasma lipoproteins in rats. J Cardiovasc Pharmacol 27 (1996) 447-454
28. Mackintosh V.S., Elsegood C.L., and Redgrave T.G. Effects of a adrenoreceptor antagonists and agonists on clearance of emulsion models of triacylglycerol-rich lipoproteins from plasma in rats. Clin Exp Pharmacol Physiol 18 (1991) 775-788
29. Yamada T., Kurasawa S., Matsuzaki M., and Tanaka A. Remnant lipoprotein metabolism is improved more when body weight is reduced by exercise than by dietary restriction. Clin Chim Acta 388 (2008) 28-32
30. Mamo J.C., Elsegood C.L., Umeda Y., Hirano T., and Redgrave T.G. Effect of probucol on plasma clearance and organ uptake of chylomicrons and VLDLs in normal and diabetic rats. Arterioscler Thromb 13 (1993) 231-239
31. Santos R.D., Sposito A.C., Ventura L.I., et al. Effect of pravastatin on plasma removal of a chylomicron-like emulsion in men with coronary artery disease. Am J Cardiol 85 (2000) 1163-1166
32. Cabezas M.C., Debruin T.W.A., Kock L.A.W., et al. Simvastatin improves chylomicron remnant removal in familial combined hyperlipidemia without changing chylomicron conversion. Metabolism 42 (1993) 497-503
33. Parhofer K.G., Barrett P.H.R., and Schwandt P. Atorvastatin improves postprandial lipoprotein metabolism in normolipidemic subjects. J Clin Endocrinol Metab 85 (2000) 4224-4230
34. Chan D.C., Watts G.F., Barrett P.H.R., et al. Effect of atorvastatin on chylomicron remnant metabolism in visceral obesity: a study employing a new stable isotope breath test. J Lipid Res 43 (2002) 706-712
35. Chan D., Watts G.F., Mori T., et al. Randomized controlled trial of the effect of n-3 fatty acid supplementation on the metabolism of apolipoprotein B-100 and chylomicron remnants in men with visceral obesity. Am J Clin Nutr 77 (2003) 300-307
36. Redgrave T.G. Chylomicron metabolism. Biochem Soc Trans 32 (2004) 79-82